QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 2 filers reported holding QIAGEN NV in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,972 | -10.1% | 6,024 | 0.0% | 0.01% | -10.0% |
| Q2 2023 | $271,261 | -2.0% | 6,024 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $276,683 | -7.9% | 6,024 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $300,417 | +21.6% | 6,024 | +0.7% | 0.01% | +7.7% |
| Q3 2022 | $247,000 | -12.4% | 5,983 | 0.0% | 0.01% | -13.3% |
| Q2 2022 | $282,000 | -3.8% | 5,983 | 0.0% | 0.02% | +7.1% |
| Q1 2022 | $293,000 | -12.0% | 5,983 | 0.0% | 0.01% | -6.7% |
| Q4 2021 | $333,000 | +7.8% | 5,983 | 0.0% | 0.02% | -6.2% |
| Q3 2021 | $309,000 | +6.9% | 5,983 | 0.0% | 0.02% | +6.7% |
| Q2 2021 | $289,000 | -0.7% | 5,983 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $291,000 | +2.5% | 5,983 | +11.2% | 0.02% | -5.6% |
| Q4 2020 | $284,000 | +1.1% | 5,382 | 0.0% | 0.02% | -14.3% |
| Q3 2020 | $281,000 | +22.2% | 5,382 | 0.0% | 0.02% | +5.0% |
| Q2 2020 | $230,000 | – | 5,382 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |